GENTIS Newborn Thalassemia Screening Test Passes International Quality Control UK NEQAS
Vietnam is one of the low-lying countries on the world map of Thalassemia (congenital hemolytic anemia) with over 12 million people carrying the disease gene and every year more than 2,000 new babies are born with the disease. Therefore, neonatal screening test (NBS) Thalassemia is extremely necessary. Understanding the importance of Thalassemia test for children's health, GENTIS has accompanied many hospitals implementing NBS to contribute to improving the quality of Vietnam's population. In particular, the most proud thing is that GENTIS' NBS Thalassemia test has passed the UK NEQAS international quality control.